In 2016, Schlingmann et al. [2] described another type of IIH (IIH type 2), which was caused by loss of function mutation of SLC34A1 and characterized by hypercalcemia, hypercalciuria, suppressed intact parathyroid hormone and hypophosphatemia. The gene discussed is SLC34A1; the disease is pseudotumor cerebri.